Using anti-B7-1 (also known as CD80) plus anti-B7-2 (also known as CD86) monoclonal antibodies, it was demonstrated that B7-1 expression on donor T cells is critical for maximal GVHD lethality induced by either CD8+ or CD4+ T cells (24). The gene discussed is CD86; the disease is graft versus host disease.